School of Medicine
Showing 1,001-1,100 of 1,146 Results
-
Aubrey Toole, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Aubrey Toole is a licensed psychologist whose research and clinical work has focused on the treatment and prevention of eating and body image problems and the potential benefits of compassion- and acceptance-based interventions. Dr. Toole further specializes in treating eating and body image concerns in high performance athletes at Stanford. Clinically, she works with a range of presentations, including eating and body image concerns, mood and anxiety difficulties, interpersonal problems, and post-traumatic stress, as well as rigid perfectionism, harsh self-critical thinking, and shame. She completed her bachelor’s degree in Psychology with Highest Honors at UC Berkeley and her Ph.D. in Clinical Psychology at Emory University. She completed her predoctoral internship at the Emory University School of Medicine Department of Psychiatry, where she worked with children, adolescents, and young adults with eating disorders, emotion regulation difficulties, anxiety, depression, OCD, and PTSD. She completed her postdoctoral fellowship at Stanford University’s School of Medicine within the Psychosocial Treatment Clinic, where her training focused on evidence-based treatments for eating disorders, anxiety and mood disorders, couples, and high-performance athletes, as well as clinical supervision.
-
Merve Topak Jamsran
Casual - Non-Exempt, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences
Current Role at StanfordResearch Assistant
-
Leonardo Tozzi
Casual - Non-Exempt, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioLeonardo Tozzi, M.D., Ph.D., graduated as a Medical Doctor from Pisa University and Sant'Anna School of Advanced Studies in 2013. In 2018, he was awarded his Ph.D. from Trinity College Dublin for his research on the impact of genetic risk factors, epigenetic modifications and environmental stressors on structural and functional brain changes related to depression.
Leonardo joined Stanford in 2018 as a post-doctoral researcher working within the framework of the Human Connectome Project. Since 2022, he leads the Computational Neuroscience & Neuroimaging Program at the Stanford Center for Precision Mental Health and Wellness.
The goal of Leonardo's research is to develop quantitative biomarkers for psychiatry that are reliable, interpretable and can be used to guide treatment selection and estimate therapy response. To this end, he integrates behavioral measures and symptoms with large scale recordings of brain structure and function as well as other biological markers.
In his free time, Leonardo enjoys practicing martial arts, playing video-games and road tripping around the USA. -
Ranak Trivedi
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsEnhancing the role of informal caregivers in chronic disease self-management; assessment and treatment of mental illness in primary care settings; psychosocial antecedents and consequences of cardiovascular disease.
-
Mickey Trockel
Professor of Psychiatry and Behavioral Sciences
BioMickey Trockel is the Director of Evidence Based Innovation for the Stanford University School of Medicine WellMD Center. His development of novel measurement tools has led to growing focus on professional fulfillment as a foundational aim of efforts to promote physician well-being. His scholarship also identifies interpersonal interactions at work as a modifiable core determinate of an organizational culture that cultivates wellness.
Dr. Trockel serves as the chair of the Physician Wellness Academic Consortium Scientific Board, which is a group of academic medical centers working together to improve physician wellbeing. The consortium sites have adopted the physician wellness assessment system Dr. Trockel and his colleagues have developed, which offers longitudinal data for benchmarking and natural experiment based program evaluation. His previous research included focus on college student health, and evaluation of the efficacy of a national evidence based psychotherapy dissemination effort. His more recent scholarship has focused on physician wellbeing. He is particularly interested in developing and demonstrating the efficacy of interventions designed to promote wellbeing by improving social culture determinants of wellbeing across student groups, employee work teams, or larger organizations. -
Themistoklis Tsarouchas
Postdoctoral Scholar, Psychiatry
BioThemis completed his PhD at the Centre for Discovery Brain Sciences of the University of Edinburgh in Scotland under Prof Catherina Becker, with focus on the contribution of the innate immune system during regeneration of the zebrafish spinal cord. As a postdoctoral researcher with Prof Anna Williams at the Centre for Regenerative Medicine in Edinburgh he worked on the molecular mechanisms that regulate the differentiation and functional maturation of human oligodendrocytes. Over the last few years, he worked on several projects focused on the identification of genes that regulate the axonal regeneration of spinal cord after injury and the differentiation of human oligodendrocyte progenitor cells into myelin producing oligodendrocytes. As a member in the Gibson lab, Themis aims to identify molecular regulators of the circadian clock and how tuning the circadian system affects the maturation and function of oligodendrocytes in health and disease.
-
Yuri Tsutsumi
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsClinical Psychology
-
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone MD, PhD is an Assistant Professor with Stanford School of Medicine’s Department of Psychiatry and Behavioral Sciences. He works collaboratively in the department’s Neuropsychiatry clinic and his clinical focus includes treating patients with diverse and complex presentations at the interface of psychiatry and neurology with particular interest in functional neurological disorders. He sees a small cohort of psychotherapy patients in Individual Psychotherapy Clinic. He also works weekend shifts on Stanford’s inpatient psychiatry units.
As a neuroscientist, he is interested in preclinical models of mental illness and investigating new therapies for mood disorders and addiction. In particular, he is interested in defining new cell types and evolutionary conserved circuits in emotional processing centers of the brain with the hope of finding new entry points for novel therapeutics. Currently under the mentorship Dr Robert Malenka, he is using optogenetic, chemogenetic, neuroimaging and behavioral approaches in mouse models of addiction to uncover vulnerable brain circuitry in opioid use disorder. Under the mentorship of Dr Alan Schatzberg he is investigating the efficacy of buprenorphine augmentation to IV ketamine infusion at reducing suicidality in treatment resistant depression.
Prior to training in psychiatry at Stanford’s research residency track Jason received his bachelor’s degree in biology and philosophy from Union College. He spent three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke investigating and developing MRI reportable contrast agents to map neuronal connectivity. Following this he entered the Medical Scientist Training Program (MD/PhD) at the State University of NY Stony Brook University. There he completed a doctoral dissertation in neuroscience under the mentorship Dr. Josh Huang at Cold Spring Harbor Laboratory. His thesis work employed mouse genetic dissections of excitatory and inhibitory cortical circuits with a focus on the circuitry of chandelier inhibitory interneurons in prefrontal cortex.
In addition to his research and clinical work, Jason is passionate about teaching, mentorship, and resident clinical supervision. He joined a working group early in his clinical residency to restructure trainee’s neuroscience education. He teaches introductory lectures in the neuroscience of addiction, PTSD, psychosis, and mood disorders. He also leads resident group supervision in their introductory psychodynamic psychotherapy clinical experience. He supervises medical students, residents, and clinical fellows in Neuropsychiatry clinic. Finally, to contribute to the Stanford clinical community, he leads a support group for Internal Medicine interns and residents. -
Laura Turner-Essel, PhD
Program Manager, Psychiatry and Behavioral Sciences
Current Role at StanfordProgram Manager, Department of Psychiatry and Behavioral Sciences
-
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
Alfredo M. Valencia
Postdoctoral Scholar, Psychiatry
BioFreddy Valencia is currently a Stanford Science Fellow and Ford Foundation Postdoctoral Scholar at Stanford University. Informed by human genetics and by combining biochemical, structural biology, and functional genomics investigative techniques, his work aims to uncover the molecular basis of human disorders and disease. His current research at Stanford University aims to investigate and characterize chromatin regulatory processes in human brain development and neurodevelopmental disorders.
-
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Peter Johannes van Roessel
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Peter van Roessel, MD PhD, completed his MD at Stanford University and his residency training in psychiatry at Columbia University and the New York-Presbyterian Hospital in New York City, with additional training in psychodynamic psychotherapy (TFP) via the Columbia University Center for Psychoanalytic Training and Research. Prior to joining the clinical faculty at Stanford, he worked for several years as Associate Director of the general research unit of the New York State Psychiatric Institute, a premier state-funded research hospital affiliated with Columbia University.
At Stanford, Dr. van Roessel sees adult mood and anxiety disorders outpatients through the Assessment Clinics and participates in resident training and patient care as director of the resident Continuity Clinic and as a supervisor in psychodynamic psychotherapy. He additionally directs the third-year resident curriculum in psychopathology and psychopharmacology. As a member of the department's Rodriguez Translational Therapeutics Lab, he sees individuals with obsessive-compulsive spectrum disorders for evaluations and research-protocol driven clinical treatment and contributes to and leads clinical neuroscience studies pioneering rapid-acting interventions in OCD. Clinically motivated research interests include the nature and neural correlates of metacognitive ‘awareness’ (insight) in OCD and related disorders, and particularly the relationship of awareness to mechanisms of attentional control.
Dr. van Roessel pursued research training in basic neuroscience prior to his clinical training, completing an MPhil in Biology via the Open University, UK, for research performed at the Max Planck Institute for Developmental Biology in Tübingen Germany, and a PhD in molecular and developmental neurobiology at the University of Cambridge, UK. He has contributed to work in the lab of Dr Julia Kaltschmidt (Stanford) on studies of GABAergic/Glutamatergic interneuronal circuity in mouse. He received a 2018 NARSAD Young Investigator Award to pursue study of nitrous oxide as a rapid-acting treatment for OCD, he was a 2020-2022 Miller Foundation Fellow, and from 2020 to 2022 was a Advanced Fellow in Mental Illness Treatment and Research via the Sierra Pacific Mental Illness Research, Education, and Clinical Center of the Palo Alto VA. Dr. van Roessel is a Fellow of the American Psychiatric Association and a member of the American College of Psychiatrists. -
Nina Vasan, MD, MBA
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsMental illness is the greatest thief of human potential today. By harnessing the power of medicine, entrepreneurship, and technology, we can return that potential to the 2 billion people suffering around the world.
Brainstorm is the world's first academic laboratory dedicated to transforming mental health through innovation and entrepreneurship. -
Cristiana Vattuone, PhD
Clinical Research Associate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Vattuone is lead clinician and researcher for the Autism and Developmental Disorders Research Program in the Division of Child Psychiatry and Behavioral Sciences. Dr. Vattuone's expertise includes clinical and neuropsychological assessment of autism spectrum disorder and associated genetic conditions. Dr. Vattuone received her Ph.D. in Human Development and Psychology from the University of California, Los Angeles with specialized training in the implementation of evidence-based interventions. Dr. Vattuone’s research efforts focus on the early identification, diagnosis, and treatment of infants and toddlers with autism spectrum disorder, developmental trajectories, and the role of the family in supporting positive outcomes. Her dedication to research, treatment, and training continues at ADDRP to support individuals with autism spectrum disorder and their families.
-
Janani Venugopalakrishnan
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsAutism spectrum disorders
-
Daniel Virtheim
Clinical Research Coordinator, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator
-
Sarina Volari
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsResearcher on hypnotically-induced near-death experiences
-
Allison Vreeland
Clinical Instructor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Postdoctoral Scholar, PsychiatryBioDr. Allison Vreeland (she/her) is a licensed clinical psychologist specializing in working with children, teens, and families. Dr. Vreeland received her PhD in Clinical Psychological Science with a minor in Quantitative Studies at Vanderbilt University. She completed her predoctoral clinical internship in Child Psychology at UCSF with specialty training through the Child Trauma Research Program. She completed a research and clinical fellowship in the Immune Behavioral Health Clinic at Stanford University, where she focused her research efforts on examining neurological markers of patients diagnosed with pediatric acute neuropsychiatric syndrome (PANS). Clinically, Dr. Vreeland’s program of clinical care is focused on the delivery of evidence-based clinical interventions for individuals with anxiety, OCD, PANS/PANDAS, mood disorders, and behavioral challenges.
-
Masataka Wada
Postdoctoral Scholar, Psychiatry
BioDr. Masataka (he/him/his) is a postdoctoral scholar in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. He is a board-certified psychiatrist and holds a PhD in neuroscience.
His clinical and research interests center on psychiatric disorders in treatment-resistant conditions. To address these challenges, Dr. Masataka is engaged in exploring electrophysiological, neuroimaging, and neuromodulation techniques, including repetitive Transcranial Magnetic Stimulation (rTMS) and Deep Brain Stimulation (DBS). He spearheaded a significant Randomized Controlled Trial (RCT) that involved 180 patients with treatment-resistant depression, aiming to develop an innovative rTMS-based treatment. His efforts have led to him receiving awards at international conferences on three occasions for his significant contributions.
Dr. Masataka's scholarly work includes publications on the electrophysiological characteristics of psychiatric disorders and the effects of neuromodulation on clinical symptoms and neuroimaging features. Additionally, he has been the recipient of two scholarships and three grants, further highlighting his contributions to the field. -
Lynn C. Waelde, Ph.D.
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioLynn C. Waelde, Ph.D. is an Adjunct Clinical Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine and Professor Emeritus in the Psychology Department at Palo Alto University. Dr. Waelde’s many collaborative publications address the impacts of traumatic events and ways to use mindfulness and meditation to promote resilience and recovery from stress and trauma. She founded and directed the Inner Resources Center which offered intervention groups and trainings to thousands of participants, clients, and therapists over the past 15 years. Dr. Waelde is the author of Mindfulness and Meditation in Trauma Treatment: The Inner Resources for Stress Program, published in 2022. She has taken a special interest in family caregivers and the Inner Resources for Stress program has been named a Best Practice by the Benjamin Rose Institute on Aging. She recently coauthored Family Caregiver Distress, which is forthcoming in 2023. She is on the editorial board of Journal of Traumatic Stress and an Associate Editor of Mindfulness.
-
Diane Elizabeth Wakeham
Clinical Research Coordinator Associate, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordClinical Research Coordinator Associate, INSPIRE Clinic, Psychiatry and Behavioral Sciences
-
Dennis Wall
Professor of Pediatrics (Clinical Informatics), of Biomedical Data Science and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsSystems biology for design of clinical solutions that detect and treat disease
-
Po Wang
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBipolar Disorders, Psychopharmacology, Treatment, Anticonvulsants, Mood stabilizers
-
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Julia Weinman
Doctoral Research Affiliate, Psych/General Psychiatry and Psychology (Adult)
BioJulia Weinman, MS, MA is a doctoral research affiliate within the Department of Psychiatry and Psychology at the Stanford School of Medicine in the Neuropsychology, Mood and Anxiety Disorder, and Women's Mental Health Lab. She is a doctoral candidate, pursuing her PhD in clinical psychology at Palo Alto University. Her research focuses on interpersonal trauma, empowerment, and post-traumatic growth. Currently, she is working with Dr. Jennifer Keller on the Building Empowerment and Resilience (BEAR) program for adult women with histories of interpersonal trauma.
-
Aileen Whyte
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Aileen Whyte, a licensed psychologist in California, brings over two decades of specialized expertise to the treatment of eating disorders in young people. Beyond her clinical practice, Dr. Whyte actively works on implementing strategies to expand the reach of evidence-based treatments for eating disorders, aiming to make these best-practice interventions more accessible to a wider population.
Dr Whyte serves as the Director of the Stanford Outpatient Child & Adolescent Eating Disorders Clinic, where she provides treatment to young people with eating disorders and provides supervision to psychology and psychiatry fellows. Dr Whyte is a certified practitioner and consultant in Family-Based Treatment (FBT) for eating disorders. She serves as a study therapist in NIMH-sponsored randomized clinical trials focused on examining FBT and related adaptations.
In addition to her clinical responsibilities, Dr. Whyte has led multiple seminars, workshops, and training sessions dedicated to the treatment of eating disorders. She provides ongoing training and consultation in FBT, reaching diverse audiences, including multidisciplinary clinicians, psychologists, and psychiatrists, within the US and internationally.
Dr. Whyte earned her PhD in Clinical Psychology from the New School for Social Research in New York. Her research and clinical interests converge on the implementation and dissemination of evidence-based treatments for eating disorders. -
Leanne Williams
Vincent V.C. Woo Professor, Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and, by courtesy, of Psychology
Current Research and Scholarly InterestsA revolution is under way in psychiatry. We can now understand mental illness as an expression of underlying brain circuit disruptions, shaped by experience and genetics. Our lab is defining precision brain circuit biotypes for depression, anxiety and related disorders. We integrate large amounts of brain imaging, behavioral and clinical data and computational approaches. Biotypes are used in personalized intervention studies with selective drugs, neuromodulation and exploratory therapeutics.
-
Nolan Williams
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator) and, by courtesy, of Radiology (Neuroimaging and Neurointervention)
BioNolan Williams, M.D. is an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Sharon E. Williams PhD
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Williams work focuses primarily on cognitive and emotional recovery of children who have been medically compromised. With improved medical treatment and increased survival rates comes the need to better understand the challenges that patients face following a life threatening illness or injury. Dr. Williams utilizes neuropsychological assessments to understand the cognitive abilities of children who have been diagnosed with cancer, head injuries, genetic disorders and other medical conditions.
-
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise on the effects of trauma across the lifespan. She provides clinical services for children, adolescents, adults, and families affected by trauma and other forms of anxiety and stress. Dr. Wilson also leads an active research program focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood. She is the Principal Investigator of GIRLTALK: We Talk, a longitudinal study funded by the National Institute of Child Health and Human Development (NICHD) that examines links from childhood violence exposure to dating violence and sexual risk in young women from low-income communities in Chicago. Dr. Wilson has authored or co-authored thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is on the editorial board of the Journal of Youth and Adolescence.
-
Shannon Wiltsey Stirman
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe overarching goal of my program of research is to determine how to facilitate access to evidence-based psychosocial interventions (EBPs) in community and public sector mental health settings. Areas of emphasis include training and consultation, treatment fidelity and adaptation, AI and digital mental health interventions, and the identification of strategies that promote sustained implementation of EBPs.
-
Britt Wray
Instructor, Psychiatry and Behavioral Sciences
BioDr. Wray is the Director of CIRCLE at Stanford Psychiatry, a research and action initiative focused on Community-minded Interventions for Resilience, Climate Leadership and Emotional wellbeing in the Stanford School of Medicine. Before this she was a Human and Planetary Health Postdoctoral Fellow at the Stanford Center for Innovation in Global Health, Stanford Woods Institute for the Environment and London School of Hygiene & Tropical Medicine. Her research focuses on the mental health impacts of climate change on young people ('emerging adults') and frontline community members, community-minded psychosocial support interventions, and public engagement for improved mental and planetary health. She is the author of two books; her latest Generation Dread: Finding Purpose in an Age of Climate Anxiety, is an impassioned generational perspective on how to stay sane amid climate disruption and was a finalist for the 2022 Governor General’s Award. She is the recipient of the 2023 Canadian Eco-Hero Award and top award winner of the National Academies Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by The National Academies of Sciences, Engineering, and Medicine. Her first book is Rise of the Necrofauna: The Science, Ethics and Risks of De-Extinction (Greystone Books 2017) and was named a "best book of the year" by The New Yorker. Dr Wray holds a PhD in Science Communication from the University of Copenhagen. She has hosted and produced several science radio programs, podcasts and television programs for international broadcasters including the BBC and CBC, and she has spoken at TED and the World Economic Forum. She is the Founder of Gen Dread (gendread.substack.com), a newsletter about building courage and taking meaningful action on the far side of climate grief.
-
Qianru Xu
Affiliate, Psych/General Psychiatry and Psychology (Adult)
Visiting Postdoctoral Scholar, Psych/General Psychiatry and Psychology (Adult)BioI am currently a postdoctoral fellow at the Center for Machine Vision and Signal Analysis at the University of Oulu, Finland, and a visiting research scholar at the Department of Psychiatry and Behavioral Sciences at Stanford University, USA. My research is deeply rooted in the study of neural signatures and their relation to behavioral changes, especially in the context of understanding emotions and associated affective disorders. The core aim of my work is to unravel the complex neural underpinnings of emotion through the Emotion AI engine, which could lead to more effective diagnostic tools and therapeutic strategies for various emotional and behavioral disturbances.
In addition to my academic and research pursuits, I love to travel and scuba dive. I've been lucky enough to visit 51 countries and have spent more than 3,000 minutes underwater. These experiences, exploring different cultures and the world, are an ongoing and cherished part of my journey.
For more information about me, please see https://frejaxu.github.io/ -
Yishan Xu, PhD, DBSM, CST
Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Xu is a licensed clinical psychologist in California, a Board-certified Behavioral Sleep Medicine Specialist, and AASECT Board-Certified Sex Therapist. She currently serves as the chair of the OPEC committee for the Society of Behavioral Sleep Medicine. She completed training at the Stanford Sleep Medicine Center 2017-2019. She has specialized training in the diagnosis and treatment of insomnia, circadian rhythm disorders, parasomnias, nightmares, and adjustment to PAP therapy for sleep apnea.
Dr. Xu grew up in China and received her Ph.D. in Clinical Psychology from the University of Virginia, VA. She has adapted treatment for insomnia for the Chinese population, and translated the book “The Rested Child” into Chinese, which is the first evidence-based book about children and teen’s sleep disorders in China. She is the founder and director of a multicultural group practice in the SF Bay Area: Mind & Body Garden Psychology Inc. She also hosts a podcast "Deep into Sleep" to help bridge the gap between public awareness and knowledge of sleep problems and the science of sleep medicine.
Publications:
Xu, Y., Barwick, F. & Li, C.(2023). Cultural Considerations in Behavioral Sleep Medicine (BSM): Telehealth Group CBT-I for Patients from a Traditional Chinese Medicine (TCM) Hospital (Submitted)
Prislin, R., Davenport, C., Xu, Y., Moreno, R., & Honeycutt, N. (2018). From marginal to mainstream and vice versa: Leaders' evaluation of diversity while in the minority versus majority. Journal of Social Issues, 74 (1), 112-128.
Attin, M., Xu, Y., Lin, C. D., & Lemus, H. (2015). A potential impact of nursing characteristics prior to in-hospital cardiac arrest: a self-reported study. Journal of Clinical Nursing, 24 (23-24), 3736-3738.
Hu, Y., Xu, Y.,& Tornello, S. L. (2015). Stability of Self-Reported Same-Sex and Both-Sex Attraction from Adolescence to Young Adulthood. Archives of sexual behavior, 1- 9.
Xu, Y., & Ocker, B. (2013). Discrepancies in Cross-cultural and cross-generational attitudes toward committed relationships in China and the United States. Family Court Review, 51 (4), 591–604.
Tornello, S. L., Emery, R., Rowen, J., Potter, D., Ocker, B., & Xu, Y. (2013). Overnight custody arrangements, attachment, and adjustment among very young children. Journal of Marriage and Family, 75 (4), 871-885.
Horn, E. E., Xu, Y., Beam, C. R., Turkheimer, E. & Emery, E. (2012). The marriage benefit? A genetically-informed study of selection and causation. Journal of Family Psychology, 27 (1), 30-41.
Prislin, R., Boyle, S. M., Davenport, C., Farley, A., Jacobs, E., Michalak, J., Uehara, K., Zandian, F., & Xu. Y. (2011). On being influenced while trying to persuade: The feedback effect of persuasion outcomes on the persuader. Social Psychological and Personality Science, 2 (1), 51-58.
Li, j., Xu, Y., & li, X. (2009). Correlation between atypical eating disorder and body- esteem of college students. Chinese Journal of Clinical Psychology, 17, 345-347.
